XOMA Stock (NASDAQ:XOMA), Quotes and News Summary

Q: What sector and industry does XOMA (XOMA) operate in?

XOMA is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

XOMA Stock (NASDAQ: XOMA) stock price, news, charts, stock research, profile.

Open	$24.280
Close	$25.440
Volume / Avg.	10.959K / 17.405K
Day Range	24.280 - 25.740
52 Wk Range	13.480 - 27.000
Market Cap	$275.634M
P/E Ratio	-
Dividend Yield	9.100%
Exchange	NASDAQ
RSI	53
Short Interest	3.54%
Days to Cover	17.84

Recent News

Lexicon Pharmaceuticals Reports Q1 Loss, Misses Revenue Estimates

Lexicon Pharmaceuticals (NASDAQ: LXRX) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items.

Zacks

Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma

XOMA acquires Kinnate Biopharma for $2.3352 per share, with potential additional cash. The acquisition is expected to close in April 2024.

Vandana Singh

Arimoclomol and Aldoxorubicin Acquisition to Bolster XOMA's Revenue Growth: Analyst

Earlier today, XOMA Corporation (NASDAQ: XOMA) acquired the royalty and milestone rights associated with two assets from LadRx Corporation: arimoclomol for Niemann-Pick disease type C, and aldoxorubicin, an albumin-linked formulation of doxorubicin

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy XOMA (XOMA) stock?

You can purchase shares of XOMA (NASDAQ: XOMA) through any online brokerage.

View our list of the best stock brokerages.

Who are XOMA's (XOMA) competitors?

Other companies in XOMA’s space includes: Zura Bio (NASDAQ:ZURA), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP) and Monte Rosa Therapeutics (NASDAQ:GLUE).

What is the target price for XOMA (XOMA) stock?

The latest price target for XOMA (NASDAQ: XOMA) was reported by HC Wainwright & Co. on Wednesday, May 1, 2024. The analyst firm set a price target for 74.00 expecting XOMA to rise to within 12 months (a possible 212.37% upside). 10 analyst firms have reported ratings in the last year.

Current Stock Price for XOMA (XOMA)?

The stock price for XOMA (NASDAQ: XOMA) is $23.69 last updated May 9, 2024 at 4:00 PM EDT.

Does XOMA (XOMA) pay a dividend?

There are no upcoming dividends for XOMA.

When is XOMA (NASDAQ:XOMA) reporting earnings?

XOMA’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Is XOMA (XOMA) going to split?

There is no upcoming split for XOMA.

What sector and industry does XOMA (XOMA) operate in?

XOMA is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-